Monoclonal antibody approved for treatment of Crohn's disease.

T. R. Freeman; P. Piascik

doi:10.1016/S1086-5802(16)30406-5

Monoclonal antibody approved for treatment of Crohn's disease.

T. R. Freeman, P. Piascik

Pharmacy Practice and Science

Producción científica: Article › revisión exhaustiva

3 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	770-772
Número de páginas	3
Publicación	Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Volumen	38
N.º	6
DOI	https://doi.org/10.1016/S1086-5802(16)30406-5
Estado	Published - 1998

Nota bibliográfica

Funding Information:
is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

Financiación

is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

Financiadores	Número del financiador
AMGen
University of Kentucky

ASJC Scopus subject areas

Pharmaceutical Science

Acceder al documento

10.1016/S1086-5802(16)30406-5

Otros archivos y enlaces

Citar esto

@article{e81904d6da5945de87a5e62690811208,

title = "Monoclonal antibody approved for treatment of Crohn's disease.",

author = "Freeman, \{T. R.\} and P. Piascik",

note = "Funding Information: is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac\textasciitilde{}andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.",

year = "1998",

doi = "10.1016/S1086-5802(16)30406-5",

language = "English",

volume = "38",

pages = "770--772",

number = "6",

}

TY - JOUR

T1 - Monoclonal antibody approved for treatment of Crohn's disease.

AU - Freeman, T. R.

AU - Piascik, P.

N1 - Funding Information: is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Phannac~andsupponed by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

PY - 1998

Y1 - 1998

UR - https://www.scopus.com/pages/publications/0032199532

UR - https://www.scopus.com/inward/citedby.url?scp=0032199532&partnerID=8YFLogxK

U2 - 10.1016/S1086-5802(16)30406-5

DO - 10.1016/S1086-5802(16)30406-5

M3 - Article

C2 - 9861797

AN - SCOPUS:0032199532

SN - 1086-5802

VL - 38

SP - 770

EP - 772

JO - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

JF - Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)

IS - 6

ER -

Monoclonal antibody approved for treatment of Crohn's disease.

Nota bibliográfica

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto